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Abstract In pancreatic L-cells, glutamate has been proposed to
mediate insulin secretion as a glucose-derived factor, although it
is also considered for its sole catabolic function. Hence, changes
in cellular glutamate levels are a matter of debate. Here, we
investigated the e¡ects of glucose and the glutamate precursor
glutamine on kinetics of glutamate levels together with insulin
secretion in INS-1E L-cells. Preincubation at low (1 mM) glu-
cose resulted in reduced cellular glutamate levels, which were
doubled by exposure to glutamine. In glutamine-deprived cells,
5 mM glucose restored glutamate concentrations. Incubation at
15 mM glucose increased cellular glutamate, along with stimu-
lation of insulin secretion, following both glutamine-free and
glutamine-rich preincubations. Nuclear magnetic resonance
(NMR) spectroscopy of INS-1E cells exposed to 15 mM
D-[1-13C]glucose revealed glutamate as the major glucose meta-
bolic product. Branched-chain amino acids, such as leucine, re-
duced cellular glutamate levels at low and intermediate glucose.
This study demonstrates that glucose stimulates glutamate gen-
eration, whereas branched-chain amino acids promote compet-
itive glutamate expenditure.
1 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Glutamate dehydrogenase (GDH; EC 1.4.1.3) is an ubiq-
uitously expressed mitochondrial enzyme, playing a major
role in glutamate turnover [1]. GDH catalyses reductive ami-
nation from K-ketoglutarate to glutamate as well as the re-
verse oxidative deamination of glutamate to K-ketoglutarate
[2]. Therefore, depending on the £ux direction, GDH could
either provide an assimilatory pathway for ammonium or play
a catabolic role for amino acids [3].
In pancreatic L-cells, some authors favour the concept that
the anaplerotic glutamate to K-ketoglutarate £ux dominates.
Consequently, amino acid-derived glutamate would stimulate
insulin secretion through the entry of K-ketoglutarate into the
tricarboxylic acid (TCA) cycle, leading to the generation of
mitochondrially-derived adenosine triphosphate (ATP). A re-
cent hypothesis suggests that glutamate, generated by cataple-
rosis from glucose-derived K-ketoglutarate, acts downstream
of mitochondrial function, participating in the coupling of
glucose metabolism to insulin secretion [4,5]. Such a model
implies that cellular glutamate concentrations are increased
upon glucose stimulation, which is the source of major de-
bates [6^8]. Several studies have observed an increase in cel-
lular glutamate contents during glucose stimulation in islets
from rat [7,9,10], mouse [7] and human [4], as well as in L-cell
lines [4,11,12]. Moreover, INS-1E cells and rat islets overex-
pressing the glutamate decarboxylating enzyme GAD65 ex-
hibit decreased glutamate levels and altered glucose-induced
insulin secretion [11].
However, other studies reported the absence of glutamate
level changes upon glucose stimulation in islets isolated from
ob/ob mice [13,14], or rats [6]. The controversy is also nourished
by demonstration that GDH activators, such as 2-aminobi-
cyclo-[2,2,1]heptane-2-carboxylic acid (BCH) and branched-
chain amino acids, promote glutamine/glutamate oxidation
with concomitant stimulation of insulin secretion [15,16].
Given the importance of the glutamate pathway in glucose-
induced insulin secretion [17], the present study reinvestigates
the role of GDH and glutamate levels in INS-1E L-cells. First,
we describe the e¡ects of glutamine during preincubation pe-
riods on the subsequent glucose-stimulated insulin secretion
and cellular glutamate levels. Second, we used 13C nuclear
magnetic resonance (NMR) to determine carbon £uxes de-
rived from labelled glucose. Third, we report the time-depen-
dent dynamic changes in glutamate contents and insulin re-
lease in cells incubated without glutamine but under di¡erent
conditions of glucose and branched-chain amino acids, both
interfering with GDH.
2. Materials and methods
2.1. Cell culture
INS-1E cells cloned from INS-1 were cultured in RPMI-1640 me-
dium supplemented with 5% foetal calf serum, 10 mM HEPES, 1 mM
pyruvate, 50 WM L-mercaptoethanol and antibiotics as described [11].
INS-1E cells from passages 52^76 were used in this study.
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2.2. Metabolism of [1-13C]glucose followed by NMR spectroscopy of
cell extracts
When con£uent, INS-1E cells grown in T175 £asks were washed
with phosphate-bu¡ered saline (PBS) and preincubated at 37‡C for 2 h
in RPMI-1640 with no glucose or glutamine. The cells were then
washed with PBS and incubated for 30 min in Krebs^Ringer bicar-
bonate bu¡er (KRB) with 2.5 mM D-[1-13C]glucose (115 mM NaCl,
4.7 mM KCl, 1.28 mM CaCl2, 1.2 mM KH2PO4, 1.2 mM
MgSO4W7H2O, 10 mM NaHCO3, 5 g/l bovine serum albumin, pH
7.4). This was followed by an incubation period of 1 h in KRB
supplemented with 15 mM [1-13C]glucose. The cells were then washed
with PBS, perchloric acid (6%) was added, and the cells were scraped
o¡ the culture £asks. The extracts of ¢ve culture £asks were pooled
and centrifuged at 1500 rpm for 5 min. As previously described [12],
the resulting supernatant was neutralised with KOH (5 M and 0.1 M
solutions) and the pellets were soaked overnight in 0.1 M NaOH
before protein measurements. The neutralised supernatant was centri-
fuged (1500 rpm, 5 min) and the supernatant was treated with Chelex-
100 resin and then lyophilised. Each experiment was carried out on at
least two independent cultures.
The lyophilised cell extracts were dissolved in 3 ml potassium phos-
phate bu¡er (100 mM, pH 7.0) and then centrifuged. The supernatant
was carefully removed and 10% D2O was added and the pH checked
and adjusted when necessary with 0.1 M NaOH and 0.1 M HCl. An
insert containing 5% v/v dioxane in water was used as an external
signal intensity reference for quanti¢cation of the NMR spectra. A
solution of L-alanine, L-glutamate, lactate and D-glucose, each at a
concentration of 100 mM, was prepared and used to quantitate con-
centrations of metabolites in the 13C spectra. Proton-decoupled 13C
spectra were acquired on a Bruker DRX 500 spectrometer using a 10
mm broad band probe. Typically spectra were acquired with 32 K
data points using 9.4 Ws pulses (90‡ pulse angle), 260 ppm spectral
width, 2 s relaxation delay and 12 000 scans. Spectra were recorded at
25‡C. Chemical shifts in aqueous media were referenced to tetrameth-
ylsilane at 0 ppm as previously described [18]. Exponential multipli-
cations with 2 Hz line broadening were performed using WINNMR
software. The assignments of the intermediate metabolites were made
by comparison with chemical shift tables in the literature [19]. The
amount of 13C in each resonance was evaluated by integration of the
extract peaks and the corresponding peaks in the standard sample
relative to the dioxane signal. Corrections for the natural abundance
signal were made. The absolute enrichments of the glutamate peaks
were related to the glutamate concentration in the extracts, deter-
mined by enzymatic methods, to give the speci¢c enrichments [20].
2.3. Concomitant static insulin release and cellular glutamate content
determination
INS-1E cells were cultured for 4^6 days with complete RPMI-1640
medium in six-well plates coated with polyornithine. KRB HEPES
bu¡er (KRBH) of the following composition was used (in mM):
135 NaCl, 3.6 KCl, 10 HEPES, 5 NaHCO3, 0.5 NaH2PO4, 0.5
MgCl2, 1.5 CaCl2, pH 7.4, glucose as indicated, bovine serum albu-
min 0.1% as carrier. Cells were preincubated for 2 h in 1 mM glucose
RPMI-1640 at 37‡C either with 2 mM of glutamine or without glu-
tamine, washed twice with glucose-free KRBH and then incubated for
60 min in KRBH plus the indicated conditions. Glucose concentra-
tions ranged from low (1 mM) to high (15 mM), according to the
sigmoidal dose response observed in these cells [4]. Incubation was
stopped by putting the plates on ice, the supernatant was collected
for insulin secretion, and 1 ml of lysis bu¡er (20 mM Tris^HCl pH
8.0, 2 mM trans-1,2-diaminocyclohexane-N,N,NP,NP-tetraacetic acid
(CTDA), 0.2% Tween-20) was added to cells.
For glutamate determination, cells were collected and rapidly soni-
cated. Following protein determination with a Bradford’s assay, glu-
tamate levels were measured in cell lysates by monitoring reduced
nicotinamide adenine dinucleotide (NADH) £uorescence augmenta-
tion during oxidation of glutamate in the cell extracts in the presence
of an excess of GDH (Boehringer Mannheim, dilution 1/100 000).
NADH £uorescence, excited at 340 nm, was measured at 460 nm in
an LS-50B £uorimeter (Perkin Elmer) before and after 30 min incu-
bation at room temperature in 1.5 ml bu¡er (50 mM Tris^HCl pH
9.5, 2.6 mM EDTA, 1.4 mM NAD, 1 mM adenosine diphosphate
(ADP)). Basal NADH was subtracted and glutamate levels were eval-
uated according to internal standards. Glutamate levels measured in
this study appear to be higher than in previous reports from the same
laboratory [4,11]. This could be explained by a recent re-evaluation of
Fig. 1. Modulation of intracellular glutamate levels by glucose in
INS-1E cells. A: INS-1E cells were preincubated 2 h in the presence
of glutamine in order to maintain the pool of glutamine/glutamate,
and then incubated for 0, 10, 30 and 60 min in the absence of glu-
tamine at di¡erent glucose concentrations. B: INS-1E cells were pre-
incubated 2 h without glutamine and then incubated for 0, 10, 30
and 60 min in the continuous absence of glutamine at di¡erent glu-
cose concentrations. C: Insulin secretion in INS-1E cells preincu-
bated 2 h in either the presence or the absence of glutamine and
then incubated 60 min without glutamine at di¡erent glucose con-
centrations. Data are the means+S.E.M. of three to seven individual
experiments done in duplicate. *P6 0.05, **P6 0.01, and
***P6 0.001 versus glucose 1 mM; 33P6 0.01 versus corresponding
groups of the glutamine-plus preincubation series.
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our internal standards and controls, although the relative values are
not modi¢ed. Insulin secretion was determined by radioimmunoassay
using rat insulin as standard.
2.4. GDH activity
The activity of puri¢ed bovine GDH was measured in the directions
of glutamate deamination as well as K-ketoglutarate amination. In the
glutamate deamination direction, the reaction mixture contained 50
mM Tris^HCl pH 9.5, 2.6 mM EDTA, 1.4 mM NAD, 5 mM L-glu-
tamate, and test compounds as indicated. GDH activity in the direc-
tion of K-ketoglutarate amination was performed in 50 mM Tris^HCl
pH 8.0, 50 mM NH4Cl, 2.6 mM EDTA, 0.15 mM NADH, 1 mM
K-ketoglutarate, and substances as indicated. Following GDH addi-
tion (0.2 Wg/ml), NADH £uorescence was monitored (excitation at
340 nm and emission at 460 nm) in 1.5 ml cuvette using an LS-50B
£uorimeter. Enzymatic activity was then evaluated from the slope of
£uorescence according to internal standards.
3. Results
First, the e¡ects of glutamine preincubation on subsequent
glucose-stimulated glutamate generation in INS-1E cells were
investigated. Cells were preincubated for 2 h in 1 mM glucose
RPMI-1640 medium with (Fig. 1A) or without (Fig. 1B) 2 mM
glutamine. INS-1E cells were subsequently incubated for 0,
10, 30 or 60 min in a glutamine-free KRBH bu¡er containing
various glucose concentrations; i.e. low (sub-physiological,
1 mM), intermediate (physiological, 5 mM), and high (supra-
physiological, 15 mM).
Cells preincubated at low glucose in the presence of 2 mM
glutamine contained glutamate levels constantly in the range
of 85^90 nmol/mg protein. Further incubation with 1 mM
glucose KRBH resulted in a progressive decrease in cellular
glutamate levels (360% after 60 min, P6 0.01, Fig. 1A) to-
wards values similar to those obtained in glutamine-depleted
cells. Under the same glutamine-rich preincubation condi-
tions, 5 mM glucose KRBH slightly increased glutamate con-
tent (+18%, P6 0.05). Finally, 15 mM glucose incubation
resulted in a progressive and sustained elevation of glutamate
levels (+78% after 1 h, P6 0.001).
Cells preincubated in glutamine-free low glucose medium
contained about half of glutamate compared to cells preincu-
bated in glutamine-rich medium. Subsequent incubation in
glutamine-free low glucose (1 mM) conditions maintained glu-
tamate contents at low levels, whereas intermediate (5 mM)
and high (15 mM) glucose concentrations markedly increased
the initial basal levels of intracellular glutamate (+125% and
+163% respectively after 1 h incubation). Interestingly, 5 mM
glucose allowed to re-establish similar levels of glutamate ob-
tained in glutamine-rich preincubated INS-1E cells, whereas
15 mM glucose markedly increased glutamate levels. There-
fore, depletion of cellular glutamate contents following gluta-
mine-free preincubation could be antagonised by elevation of
glucose from 1 to approximately 5 mM.
As shown in Fig. 1C, both in the presence and absence of
glutamine during preincubation periods, insulin secretion lev-
els were uniformly glucose dose dependent. Insulin release at
low glucose was elevated in the presence of glutamine,
although the secretory responses at intermediate or high glu-
cose were not signi¢cantly a¡ected by the preincubation con-
ditions.
Second, we performed NMR spectroscopy on [1-13C]-
glucose-labelled INS-1E cells in order to determine the meta-
bolic fate of glucose. The 1H-decoupled 13C-NMR spectra of
cellular extracts obtained after 1 h incubation of INS-1E cells
with 15 mM [1-13C]glucose showed that glucose metabolism
produced, apart from CO2, almost exclusively glutamate (Fig.
2). Glutamate appeared labelled at positions C2 (56.0 ppm),
C3 (34.7 ppm) and C4 (28.1 ppm) indicating that pyruvate
entered the TCA cycle via both pyruvate dehydrogenase- and
pyruvate carboxylase-mediated pathways. The percentage 13C
enrichments for glutamate were found to be the following: C2
(25.7 Q 3.1%), C3 (21.5 Q 1.1%) and C4 (46.7 Q 2.9%).
Third, time-dependent e¡ects of leucine on INS-1E intra-
cellular glutamate contents were measured. INS-1E cells were
preincubated for 2 h in 1 mM glucose plus 2 mM glutamine
medium, then incubated in a glutamine-free KRBH contain-
ing di¡erent glucose concentrations in the presence or absence
of 5 mM leucine, serving as nutrient as well as potent GDH
activator [17]. In the presence of 1 mM glucose (Fig. 3A),
leucine rapidly decreased the glutamate content towards a
near total depletion after 1 h (391%, P6 0.001). In the pres-
ence of 5 mM glucose (Fig. 3B), leucine induced a progressive
decrease in glutamate levels, although at 15 mM glucose (Fig.
3C) glutamate levels were maintained at the elevated values
obtained during the preincubation period. Insulin secretion
was stimulated both by glucose and leucine (Fig. 3D). There-
fore, in INS-1E cells incubated in glutamine-free bu¡er, 5 mM
leucine promoted glutamate consumption and disrupted equi-
librium obtained with 5 mM glucose alone. Noteworthy, when
expressed in percentage, the decreasing e¡ect of leucine is
more important as the glucose concentration is low.
Next, we tested the e¡ects of di¡erent branched-chain ami-
no acids on cellular glutamate levels and insulin release in the






























































Fig. 2. Metabolism of glucose followed by NMR spectroscopy of cell extracts. Proton-decoupled 13C-NMR spectrum of extracts from INS-1E
cells obtained after incubation for 1 h with 15 mM glucose.
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Fig. 4. Modulation of intracellular glutamate levels and insulin re-
lease by branched-chain amino acids in INS-1E. A, B; INS-1E cells
were preincubated 2 h in the presence of glutamine, then incubated
for 60 min without glutamine at 1 mM (dotted bars), 5 mM (diago-
nally stripped bars) or 15 mM glucose concentrations (vertically
stripped bars) in the presence of leucine, isoleucine or BCH as in-
dicated. Intracellular glutamate levels are shown in A and insulin
release in B. Data are means+S.E.M. of three to eight individual
observations done in duplicate. At 1 mM and 5 mM glucose:
P6 0.001 for all values with branched-chain amino acids versus
control. At 15 mM glucose, P6 0.01 for all values with branched-
chain amino acids versus control in A except for leucine 0.5 mM
(P6 0.05) and isoleucine (not signi¢cant (NS)), whereas in B all val-
ues are NS versus control.
Fig. 3. Modulation of intracellular glutamate levels by leucine in
INS-1E cells. A^C: INS-1E cells were preincubated 2 h in the pres-
ence of glutamine and then incubated for 0, 10, 30 and 60 min
without glutamine at 1 mM (A), 5 mM (B), 15 mM (C) glucose
concentrations in the presence (black symbols) or absence (white
symbols) of 5 mM leucine. Data in A, B and C are the means
+S.E.M. of three to seven individual experiments done in duplicate.
D: Insulin secretion in INS-1E cells preincubated 2 h in the pres-
ence of glutamine, then incubated for 60 min without glutamine at
1, 5, and 15 mM glucose in the presence (leucine 5 mM) or absence
(control) of leucine. Data are the means+S.E.M. of four to nine in-
dividual experiments. *P6 0.05, **P6 0.01, and ***P6 0.001 versus
corresponding controls without leucine. C: ***P6 0.001 versus glu-
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were preincubated at low glucose 2 mM glutamine medium
and subsequently incubated for 60 min in glutamine-free
KRBH. At 1 and 5 mM glucose, leucine dose dependently
decreased cellular glutamate contents and stimulated insulin
release (Fig. 4). BCH (5 mM), the non-metabolisable analogue
of leucine, mimicked the e¡ects of 5 mM leucine on glutamate
levels and insulin release, whereas 5 mM isoleucine exhibited
only moderate e¡ects compared to those of leucine.
At high glucose (15 mM), leucine slightly decreased gluta-
mate levels, still in a dose-dependent manner, although to
lesser extents than those observed at lower glucose concentra-
tions, and leucine stimulated insulin release. Isoleucine had no
signi¢cant e¡ects on glutamate levels and insulin secretion
under elevated glucose, whereas 5 mM BCH was still nearly
as e¡ective as 5 mM leucine.
At ¢xed concentrations of branched-chain amino acids, glu-
cose always increased glutamate levels concomitantly with
stimulation of insulin release, whereas at ¢xed glucose concen-
trations, amino acids decreased cellular levels of glutamate.
Finally, in vitro measurements of GDH activity in the di-
rection of K-ketoglutarate amination as well as in the direc-
tion of glutamate deamination showed that the £ux through
GDH is similarly controlled in both directions (Fig. 5). As
expected [21,22], ADP increased, whereas guanosine triphos-
phate (GTP) decreased GDH activity. GDH was activated in
both directions by leucine, as low as micromolar concentra-
tions, however isoleucine was a weak activator. BCH e¡ects
were comparable to those of leucine, while glucose did not
modify GDH activity (data not shown).
4. Discussion
E¡ects of glucose on glutamate levels in L-cells are a matter
of debate. In the present study, we monitored cellular gluta-
mate levels in INS-1E L-cells incubated under di¡erent culture
conditions. In particular, we tested glucose concentrations
ranging from sub- to supra-physiological levels (1 to 15 mM
respectively). The results demonstrate that glutamate levels
are highly modulated, either increased by glucose and gluta-
mine, or decreased by branched-chain amino acids. Similar
glutamate levels can be obtained either in the presence of
5 mM glucose without glutamine or by exposure to glutamine
(2 mM) at low glucose (1 mM).
Leucine decreased glutamate levels and its non-metabolis-
able analogue BCH displayed similar e¡ects. This strongly
suggests that most of leucine e¡ects are associated with its
activation of GDH rather than its direct metabolism as nu-
trient. It also shows the implication of GDH in the branched-
chain amino acid-mediated lowering e¡ects of glutamate lev-
els. Leucine depleted the glutamate pool at low glucose, but
established a steady state at 15 mM glucose when glucose and
leucine e¡ects on GDH antagonise [23]. These data are in
agreement with previous reports showing that glucose regu-
lates glutaminolysis, glutamate fate and insulin secretion
through inhibition of GDH [23,24].
The present study reveals that glucose and branched-chain
amino acids interact on L-cell glutamate content through their
respective opposite e¡ects on GDH. Whereas branched-chain
amino acids clearly reduced glutamate levels at low and inter-
mediate glucose concentrations, elevation of glucose was ac-
companied by an increase in cellular glutamate pool in all
conditions. Therefore, GDH could act in anaplerotic and cat-
aplerotic directions, i.e. stimulation of glutaminolysis to form
glutamate and consequently K-ketoglutarate, as well as gen-
eration of glutamate from K-ketoglutarate. The latter model is
supported by NMR spectroscopy showing that glutamate,
upon glucose stimulation, is the major metabolic product
from labelled glucose in INS-1E cells (Fig. 2), which is in
accordance with results obtained in BRIN-BD11 cells [12].
Another NMR study performed in INS-1-832/13 cells also
reported enrichment of glutamate with glucose carbons,
although the total glutamate concentration was unchanged
[25].
Taken together, these results suggest that glutamate might
have at least two e¡ects in L-cells. At low glucose, GDH
favours the £ux of oxidative deamination of glutamate to
K-ketoglutarate, glutamate being preferentially used as an
anaplerotic fuel for the L-cell due to its position at the cross-
road of amino acid catabolism. This would ensure minimal
requirement for TCA cycle activity and ATP generation. At
elevated glucose, GDH and/or transamination reactions
would favour glutamate generation that could then play a
messenger role outside mitochondria in the ampli¢cation
pathway of glucose-induced insulin secretion [4,26].
Fig. 5. E¡ects of branched-chain amino acids and nucleotides on in
vitro GDH activity. Bovine liver GDH activity was measured in the
direction of reductive amination (A) or in the direction of oxidative
deamination (B). K-Ketoglutarate (1 mM) and L-glutamate (5 mM)
were used as substrates in A and B respectively. Data are mean-
s+S.E.M. of three to ¢ve individual observations.
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Recent reports showed either an increase [7] or no change
[6] in islet glutamate contents upon glucose stimulation. The
present data demonstrate that both e¡ects could be observed
depending on culture conditions imposed to the cells. There-
fore, the £ux direction depends on the nutritional level of the
cell, i.e. the concomitant concentrations of glucose, glutamine,
and branched-chain amino acids. In vitro, drastic and speci¢c
experimental conditions restrict the observation to one unique
GDH £ux direction. In vivo, L-cell nutritional environment
does not vary so drastically and glutamate pool could be near
equilibrium, changes in substrate levels inducing only subtle
changes of GDH £ux and glutamate pool. Investigating this
complex equilibrium will contribute to our understanding of
L-cell function.
Acknowledgements: We gratefully thank G. Cha¡ard for expert tech-
nical assistance as well as C.B. Wollheim, R. Gross and G. Ribes for
stimulating discussions. We also thank J.P.G. Malthouse and C. Hew-
age for support for the NMR work. We would like to acknowledge
the Wellcome Trust (grant 055637/z/98) for funding the DRX 500
spectrometer and for supporting C.H. This study was supported by
the Swiss National Science Foundation (grant No. 31-67023.01, to
P.M.) and Dr. Max Cloetta Foundation (Zurich, to P.M.). L.B. was
a recipient of a Health Research Board (Dublin) postdoctoral fellow-
ship.
References
[1] Hudson, R.C. and Daniel, R.M. (1993) Comp. Biochem. Physiol.
B 106, 767^792.
[2] Nissim, I. (1999) Am. J. Physiol. 277, F493^497.
[3] Owen, O.E., Kalhan, S.C. and Hanson, R.W. (2002) J. Biol.
Chem. 277, 30409^30412.
[4] Maechler, P. and Wollheim, C.B. (1999) Nature 402, 685^689.
[5] Hoy, M., Maechler, P., Efanov, A.M., Wollheim, C.B., Berggren,
P.O. and Gromada, J. (2002) FEBS Lett. 531, 199^203.
[6] MacDonald, M.J. and Fahien, L.A. (2000) J. Biol. Chem. 275,
34025^34027.
[7] Bertrand, G., Ishiyama, N., Nenquin, M., Ravier, M.A. and
Henquin, J.C. (2002) J. Biol. Chem. 277, 32883^32891.
[8] Maechler, P. (2002) Cell Mol. Life. Sci. 59, 1803^1818.
[9] Sener, A. and Malaisse, W.J. (1987) Biochem. J. 246, 89^95.
[10] Liu, Y.Q., Montanya, E. and Leahy, J.L. (2001) Diabetologia 44,
1026^1033.
[11] Rubi, B., Ishihara, H., Hegardt, F.G., Wollheim, C.B. and
Maechler, P. (2001) J. Biol. Chem. 276, 36391^36396.
[12] Brennan, L., Shine, A., Hewage, C., Malthouse, J.P., Brindle,
K.M., McClenaghan, N., Flatt, P.R. and Newsholme, P. (2002)
Diabetes 51, 1714^1721.
[13] Danielsson, A., Hellman, B. and Idahl, L.A. (1970) Horm.
Metab. Res. 2, 28^31.
[14] Gylfe, E. and Hellman, B. (1974) Endocrinology 94, 1150^1156.
[15] Malaisse, W.J., Sener, A., Malaisse-Lagae, F., Welsh, M., Mat-
thews, D.E., Bier, D.M. and Hellerstrom, C. (1982) J. Biol.
Chem. 257, 8731^8737.
[16] Lenzen, S., Rustenbeck, I. and Panten, U. (1984) J. Biol. Chem.
259, 2043^2046.
[17] Kelly, A., Li, C., Gao, Z., Stanley, C.A. and Matschinsky, F.M.
(2002) Diabetes 51 (Suppl. 3), S421^426.
[18] Finucane, M.D., Hudson, E.A. and Malthouse, J.P. (1989) Bio-
chem. J. 258, 853^859.
[19] Fan, T.W.M. (1996) Prog. NMR Spectrosc. 28, 161^219.
[20] Chateil, J.F., Biran, M., Thiaudie're, E., Canioni, P. and Merle,
M. (2001) Neurochem. Int. 38, 399^407.
[21] Fisher, H.F. (1985) Methods Enzymol. 113, 16^27.
[22] Smith, T.J., Peterson, P.E., Schmidt, T., Fang, J. and Stanley,
C.A. (2001) J. Mol. Biol. 307, 707^720.
[23] Gao, Z.Y., Li, G., Naja¢, H., Wolf, B.A. and Matschinsky, F.M.
(1999) Diabetes 48, 1535^1542.
[24] Li, C., Naja¢, H., Daikhin, Y., Nissim, I.B., Collins, H.W.,
Yudko¡, M., Matschinsky, F.M. and Stanley, C.A. (2003)
J. Biol. Chem. 278, 2853^2858.
[25] Lu, D., Mulder, H., Zhao, P., Burgess, S.C., Jensen, M.V., Kam-
zolova, S., Newgard, C.B. and Sherry, A.D. (2002) Proc. Natl.
Acad. Sci. USA 99, 2708^2713.
[26] Bai, L., Zhang, X. and Ghishan, F.K. (2003) Am. J. Physiol.
Gastrointest. Liver Physiol. 284, G808^814.
FEBS 27329 3-6-03
C. Broca et al./FEBS Letters 545 (2003) 167^172172
